The cancer changes the growth and development of leukocytes (white blood cells), and the stem cells from which they develop. The deadliest type of blood cancer is generally considered to be acute ...

Acute myeloid leukemia (AML) is one of the most common hematologic malignancies that is characterized by clonal expansion of abnormally differentiated myeloid blasts (1, 2). High treatment failure ...

The team identified a specific population of immune cells that play a critical role in successful treatment of relapsed acute myeloid leukemia (AML). A research team from Columbia Engineering and ...

The two main types of acute leukemia are acute lymphocytic leukemia (ALL) and acute myeloid leukemia (AML). Each can cause symptoms over days or weeks, including: Chronic leukemia causes problems in ...

Aug. 21, 2024 — An international team of scientists has uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their growth. AML cells prevent the synthesis of proteins that ...

Myelodysplasticsyndrome (MDS) and acute myeloid leukemia (AML) are clonal hematopoietic stem cell diseases leading to an insufficient formation of functional blood cells. Disease-immanent factors as ...

Patients with high-risk AML, that is, megakaryoblastic leukemia (M7), RAEB-T, secondary AML, -7, 5q-, t(9;22) or persistent leukemia after DAV 1, were eligible for allogeneic hematopoietic stem ...

This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...

B-cell prolymphocytic leukemia (B-PLL) is a rare, aggressive type of leukemia that progresses rapidly. People with B-PLL typically have a less favorable outlook. However, new targeted treatments ...

The code is released under the version 3 of the GNU General Public License.